Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 3
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study.
Dommasch M, Steger A, Barthel P, Huster KM, Müller A, Sinnecker D, Laugwitz KL, Penzel T, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri HV, Bauer A, Malik M, Zabel M, Schmidt G; EU-CERT-ICD investigators. Dommasch M, et al. EClinicalMedicine. 2020 Dec 21;31:100695. doi: 10.1016/j.eclinm.2020.100695. eCollection 2021 Jan. EClinicalMedicine. 2020. PMID: 33554086 Free PMC article.
Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.
Junttila MJ, Pelli A, Kenttä TV, Friede T, Willems R, Bergau L, Malik M, Vandenberk B, Vos MA, Schmidt G, Merkely B, Lubinski A, Svetlosak M, Braunschweig F, Harden M, Zabel M, Huikuri HV, Sticherling C; EU-CERT-ICD Investigators. Junttila MJ, et al. Diabetes Care. 2020 Jan;43(1):196-200. doi: 10.2337/dc19-1014. Epub 2019 Oct 23. Diabetes Care. 2020. PMID: 31645407
Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
Bauer A, Klemm M, Rizas KD, Hamm W, von Stülpnagel L, Dommasch M, Steger A, Lubinski A, Flevari P, Harden M, Friede T, Kääb S, Merkely B, Sticherling C, Willems R, Huikuri H, Malik M, Schmidt G, Zabel M; EU-CERT-ICD investigators. Bauer A, et al. Lancet. 2019 Oct 12;394(10206):1344-1351. doi: 10.1016/S0140-6736(19)31996-8. Epub 2019 Sep 2. Lancet. 2019. PMID: 31488371 Free article. Clinical Trial.
Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies.
Reichlin T, Asatryan B, Vos MA, Willems R, Huikuri HV, Junttila MJ, Schlögl SC, Hnatkova K, Schaer BA, Malik M, Zabel M, Sticherling C; EU-CERT-ICD Investigators. Reichlin T, et al. Heart Rhythm. 2020 Oct;17(10):1664-1671. doi: 10.1016/j.hrthm.2020.05.016. Epub 2020 May 17. Heart Rhythm. 2020. PMID: 32428669
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.
Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, Zürn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators. Sticherling C, et al. Europace. 2018 Jun 1;20(6):963-970. doi: 10.1093/europace/eux176. Europace. 2018. PMID: 29016784 Free PMC article.